Remove Capital Remove Invest Remove Thousand Oaks
article thumbnail

Amgen's Kevin Sharer Joins Healthcare Venture Capital Firm

socalTECH

Is Amgen the next source of the healthcare industry's venture capital deals? It might be, on news that Kevin Sharer , the former CEO of Thousand Oaks-based Amgen , has joined venture capital investment firm Foundation Medical Partners. READ MORE>>.

article thumbnail

Ocean Aero Gets Investment From Teledyne For Ocean Robots

socalTECH

San Diego-based Ocean Aero , a developer of unmanned, autonomous marine vehicles, has scored funding from Thousand Oaks-based Teledyne , the companies said this morning. Financial terms of the investment were not disclosed. According to Teledyne, the investment also included a strategic partnership deal. READ MORE>>.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Amgen Adds To Sutro Biopharma Investment

socalTECH

Thousand Oaks-based Amgen has returned as one of the investors in cancer therapeutis developer Sutro Biopharma , as part of an $85.4M funding round. South San Francisco-based Sutro Biopharma said last week that it has raised $85.4M in a Series E funding round.

article thumbnail

Amgen Leads Investment In SiteOne Therapeutics

socalTECH

Thousand Oaks-based Amgen is the lead investor in a round for San Francisco- and Bozeman, Montana-based SiteOne Therapeutics , SiteOne said on Friday. SiteOne said it raised $15M in a Series B funding round, which was led b Amgen, and also included Next Frontier Capital and insiders.

article thumbnail

Atara Biotherapeutics CEO Steps Down

socalTECH

Atara Biotherapeutics , the biopharmaceuticals firm which has its manufacturing and research efforts based in Thousand Oaks, said on Thursday that its current President and CEO, Isaac Ciechanover, M.D., The company is based in South San Francisco, but was founded in Thousand Oaks and has a large facility in the city.

article thumbnail

Dantari Gets $47M For Tumor Medicine Effort

socalTECH

Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases. Dantari has appointed Richard A. Markus, M.D., a co-founding managing director at Westlake.

article thumbnail

Teledyne Invests In Optical Alchemy

socalTECH

Thousand Oaks-based Teledyne Technologies announced today that it has acquired a minority interest in Optical Alchemy , a Nashua, New Hampshire-based designer and manufacturer of ultra-light electro optical gimbal systems. Financial terms of the investment were not disclosed. READ MORE>>.

Invest 150